Nanion コーポレートブログ


30.03.2022: Nanion Newsbites - Neuromuscular AChR α1ß1γδ receptors

Nanion Newsbites: Neuromuscular AChR α1ß1γδ receptors

In the latest edition of our quarterly newsletter, we recap the following:

Press Release:
SyncroPatch 384 installed at the Food and Drug Administration (FDA) at their Silver Spring site in Maryland; The SyncroPatch 384 will be used for high throughput automated patch clamp experiments for cardiac safety experiments.

Featured Application Note:
Here we show cardiac ion channel recordings from hiPSC-CMs or overexpressing cell lines generated with the world’s smallest patch clamp setups: Port-a-Patch and Port-a-Patch mini.

Featured Video:
Did you know that you can literally turn the SyncroPatch 384 into a lower throughput instrument with the 32-well mode of operation?  You don't have to use the whole chip in one run, you can use part of the chip and save the rest of the chip to be used over several days. This way, you can take full advantage of the very low cost per data point of the 384-well chips. Watch the video here

Access the complete newsletter here

Register for our newsletter here 
(please note that you can unsubscribe or edit your email preferences at anytime)


We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.